117 related articles for article (PubMed ID: 7779975)
1. [Structure and biological properties of a conjugate of Bowman-Birk type soy proteinase inhibitor with a block copolymer of ethylene oxide and propylene oxide].
Gladysheva IP; Polekhina OV; Shen WC; Shevchenko AA; Kazanskaia NF; Larionova NI
Biokhimiia; 1995 Apr; 60(4):523-32. PubMed ID: 7779975
[TBL] [Abstract][Full Text] [Related]
2. [Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide].
Larionova NI; Gladysheva IP; Topchieva IN; Kazanskaia NF
Biokhimiia; 1993 Oct; 58(10):1658-64. PubMed ID: 8268307
[TBL] [Abstract][Full Text] [Related]
3. Proteinase inhibition using small Bowman-Birk-type structures.
Fernandez JH; Mello MO; Galgaro L; Tanaka AS; Silva-Filho MC; Neshich G
Genet Mol Res; 2007 Oct; 6(4):846-58. PubMed ID: 18058707
[TBL] [Abstract][Full Text] [Related]
4. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
Ekrami H; Kennedy AR; Witschi H; Shen WC
J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
[TBL] [Abstract][Full Text] [Related]
5. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.
Larionova NI; Gladysheva IP; Polekhina OV; Kurochkina LP; Gorbatova EN
Appl Biochem Biotechnol; 1996; 61(1-2):139-48. PubMed ID: 9100351
[TBL] [Abstract][Full Text] [Related]
7. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
Weder JK; Hinkers SC
J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
[TBL] [Abstract][Full Text] [Related]
8. Binding of the soybean Bowman-Birk proteinase inhibitor and of its chymotrypsin and trypsin inhibiting fragments to bovine alpha-chymotrypsin and bovine beta-trypsin. A thermodynamic study.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
J Mol Recognit; 1990; 3(5-6):192-6. PubMed ID: 2096886
[TBL] [Abstract][Full Text] [Related]
9. Effects of Disulfide Bond Reduction on the Conformation and Trypsin/Chymotrypsin Inhibitor Activity of Soybean Bowman-Birk Inhibitor.
He H; Li X; Kong X; Zhang C; Hua Y; Chen Y
J Agric Food Chem; 2017 Mar; 65(11):2461-2467. PubMed ID: 28249116
[TBL] [Abstract][Full Text] [Related]
10. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G].
Gladysheva IP; Larionova NI; Gladyshev DP; Tikhonova TV; Kazanskaia NF
Biokhimiia; 1994 Apr; 59(4):513-8. PubMed ID: 8018773
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor].
Larionova NI; Gladysheva IP; Tikhonova TV; Kazanskaia NF
Biokhimiia; 1993 Aug; 58(9):1437-44. PubMed ID: 8218567
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues.
Miles SM; Leatherbarrow RJ; Marsden SP; Coates WJ
Org Biomol Chem; 2004 Feb; 2(3):281-3. PubMed ID: 14747852
[TBL] [Abstract][Full Text] [Related]
13. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor.
Bueno NR; Fritz H; Auerswald EA; Mentele R; Sampaio M; Sampaio CA; Oliva ML
Biochem Biophys Res Commun; 1999 Aug; 261(3):838-43. PubMed ID: 10441512
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
16. Soybean bowman--birk inhibitor conjugates with clinical dextran. synthesis and antiproteolytic activity.
Gladysheva IP; Moroz NA; Papisova AI; Larionova NI
Biochemistry (Mosc); 2001 Apr; 66(4):384-9. PubMed ID: 11403644
[TBL] [Abstract][Full Text] [Related]
17. Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
McBride JD; Watson EM; Brauer AB; Jaulent AM; Leatherbarrow RJ
Biopolymers; 2002; 66(2):79-92. PubMed ID: 12325158
[TBL] [Abstract][Full Text] [Related]
18. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds.
Scarafoni A; Consonni A; Galbusera V; Negri A; Tedeschi G; Rasmussen P; Magni C; Duranti M
Phytochemistry; 2008 Jun; 69(9):1820-5. PubMed ID: 18474386
[TBL] [Abstract][Full Text] [Related]
20. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
